Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
$59.83
-2.7%
$57.69
$39.35
$63.33
$121.40B0.4311.67 million shs10.81 million shs
Investar Holding Co. stock logo
ISTR
Investar
$16.91
+0.1%
$19.13
$14.60
$24.81
$166.19M0.8141,228 shs25,930 shs
The J. M. Smucker Company stock logo
SJM
J. M. Smucker
$111.01
-2.8%
$106.52
$98.77
$127.59
$11.81B0.281.12 million shs1.19 million shs
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
-2.43%+3.29%+7.93%+8.51%+13.02%
Investar Holding Co. stock logo
ISTR
Investar
-0.88%-5.01%-13.16%-27.14%+5.56%
The J. M. Smucker Company stock logo
SJM
J. M. Smucker
-2.47%+3.94%+10.56%+0.82%-6.09%
Remove Ads
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
4.3411 of 5 stars
2.23.04.24.03.53.30.0
Investar Holding Co. stock logo
ISTR
Investar
4.6564 of 5 stars
2.34.02.53.12.70.83.8
The J. M. Smucker Company stock logo
SJM
J. M. Smucker
4.0809 of 5 stars
2.14.04.21.32.02.51.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
2.32
Hold$57.86-3.29% Downside
Investar Holding Co. stock logo
ISTR
Investar
2.50
Moderate Buy$20.5021.23% Upside
The J. M. Smucker Company stock logo
SJM
J. M. Smucker
2.22
Hold$126.0013.50% Upside

Current Analyst Ratings Breakdown

Latest ISTR, SJM, and BMY Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/11/2025
The J. M. Smucker Company stock logo
SJM
J. M. Smucker
DA Davidson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$122.00 ➝ $120.00
3/3/2025
The J. M. Smucker Company stock logo
SJM
J. M. Smucker
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$123.00 ➝ $119.00
2/21/2025
Investar Holding Co. stock logo
ISTR
Investar
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageNeutral$21.00
2/7/2025
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$60.00 ➝ $62.00
2/4/2025
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$50.00 ➝ $55.00
1/28/2025
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$60.00 ➝ $65.00
1/24/2025
The J. M. Smucker Company stock logo
SJM
J. M. Smucker
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$125.00 ➝ $120.00
1/8/2025
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$62.00 ➝ $65.00
1/8/2025
The J. M. Smucker Company stock logo
SJM
J. M. Smucker
TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Hold$130.00 ➝ $121.00
12/16/2024
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$63.00 ➝ $70.00
(Data available from 3/12/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
$48.30B2.51$6.31 per share9.48$8.08 per share7.40
Investar Holding Co. stock logo
ISTR
Investar
$82.41M2.02$2.04 per share8.28$23.25 per share0.73
The J. M. Smucker Company stock logo
SJM
J. M. Smucker
$8.79B1.34$14.31 per share7.76$72.46 per share1.53
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
-$8.95B-$4.42N/A9.822.07-18.53%13.93%2.46%4/24/2025 (Estimated)
Investar Holding Co. stock logo
ISTR
Investar
$20.25M$2.048.297.17N/A12.81%8.00%0.67%4/28/2025 (Estimated)
The J. M. Smucker Company stock logo
SJM
J. M. Smucker
$744M-$2.4122.4710.653.915.96%14.35%5.44%N/A

Latest ISTR, SJM, and BMY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
2/27/2025Q3 2025
The J. M. Smucker Company stock logo
SJM
J. M. Smucker
$2.37$2.61+$0.24-$6.22$2.23 billion$2.19 billion
2/6/2025Q4 2024
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
$1.47$1.67+$0.20$0.04$11.57 billionN/A
1/23/2025Q4 2024
Investar Holding Co. stock logo
ISTR
Investar
$0.39$0.65+$0.26$0.69$20.60 millionN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
$2.484.15%+6.38%N/A 17 Years
Investar Holding Co. stock logo
ISTR
Investar
$0.422.48%+9.77%20.59%N/A
The J. M. Smucker Company stock logo
SJM
J. M. Smucker
$4.323.89%+4.23%N/A 27 Years

Latest ISTR, SJM, and BMY Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/3/2025
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
quarterly$0.624.14%4/4/20254/4/20255/1/2025
1/24/2025
The J. M. Smucker Company stock logo
SJM
J. M. Smucker
quarterly$1.084.17%2/14/20252/14/20253/3/2025
12/18/2024
Investar Holding Co. stock logo
ISTR
Investar
quarterly$0.10501.9%12/31/202412/31/20241/31/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
2.90
1.25
1.15
Investar Holding Co. stock logo
ISTR
Investar
0.85
0.95
0.95
The J. M. Smucker Company stock logo
SJM
J. M. Smucker
0.89
0.58
0.27

Institutional Ownership

CompanyInstitutional Ownership
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
76.41%
Investar Holding Co. stock logo
ISTR
Investar
50.17%
The J. M. Smucker Company stock logo
SJM
J. M. Smucker
81.66%

Insider Ownership

CompanyInsider Ownership
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
0.09%
Investar Holding Co. stock logo
ISTR
Investar
8.73%
The J. M. Smucker Company stock logo
SJM
J. M. Smucker
3.40%
CompanyEmployeesShares OutstandingFree FloatOptionable
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
34,1002.03 billion2.03 billionOptionable
Investar Holding Co. stock logo
ISTR
Investar
3409.83 million8.97 millionNot Optionable
The J. M. Smucker Company stock logo
SJM
J. M. Smucker
9,000106.42 million102.80 millionOptionable

Recent News About These Companies

DA Davidson Cuts J. M. Smucker (NYSE:SJM) Price Target to $120.00
J. M. Smucker (NYSE:SJM) Rating Increased to Hold at StockNews.com
JM Smucker (SJM) Gets a Hold from D.A. Davidson
J.M. Smucker price target lowered to $120 from $122 at DA Davidson
J. M. Smucker Q4 EPS Forecast Decreased by William Blair

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Bristol-Myers Squibb stock logo

Bristol-Myers Squibb NYSE:BMY

$59.82 -1.69 (-2.74%)
Closing price 03:59 PM Eastern
Extended Trading
$59.83 +0.00 (+0.01%)
As of 07:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, and neuroscience diseases. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation, and for the treatment of DVT/PE; Opdivo for various anti-cancer indications, including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, stomach and esophageal cancer; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of multiple myeloma; Abecma for the treatment of relapsed or refractory multiple myeloma; Reblozyl for the treatment of anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of relapsed or refractory large B-cell lymphoma; Onureg for the treatment of AML; Inrebic for the treatment of myelofibrosis; Camzyos for the treatment of symptomatic obstructive HCM to enhance functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; and Abraxane to treat breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.

Investar stock logo

Investar NASDAQ:ISTR

$16.87 -0.02 (-0.09%)
As of 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Investar Holding Corporation operates as the bank holding company for Investar Bank that provides a range of commercial banking products to individuals, professionals, and small to medium-sized businesses in south Louisiana, southeast Texas, and Alabama in the United States. The company offers various deposit products and services, such as savings, checking, money market, and individual retirement accounts, as well as various certificates of deposit; debit and credit cards; internet, mobile, and video banking services; and reciprocal deposit products. It also provides commercial real estate loans; commercial and industrial loans, including working capital lines of credit and equipment loans; loans for the construction of commercial projects, and single family residential and multifamily properties; one-to-four family residential real estate loans, such as second mortgage loans; and consumer loans, such as secured and unsecured installment and term loans, home equity loans and lines of credit, and auto loans, as well as loans for personal, family, and household purposes. In addition, the company offers treasury management products, including remote deposit capture, lockbox payment processing, virtual vault, positive pay, ACH origination, wire transfer, investment sweep accounts, and business internet banking services. Further, it provides various other banking services, such as cashiers' checks, direct deposit of payroll and social security checks, night depository, bank-by-mail, automated teller machines, electronic statements, interactive teller machines, online account opening, and mobile wallet payment services. Investar Holding Corporation was founded in 2006 and is headquartered in Baton Rouge, Louisiana.

J. M. Smucker stock logo

J. M. Smucker NYSE:SJM

$111.01 -3.25 (-2.84%)
Closing price 03:59 PM Eastern
Extended Trading
$115.12 +4.11 (+3.71%)
As of 07:25 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

The J. M. Smucker Company manufactures and markets branded food and beverage products worldwide. It operates in three segments: U.S. Retail Pet Foods, U.S. Retail Coffee, and U.S. Retail Consumer Foods. The company offers mainstream roast, ground, single serve, and premium coffee; peanut butter and specialty spreads; fruit spreads, toppings, and syrups; jelly products; nut mix products; shortening and oils; frozen sandwiches and snacks; pet food and pet snacks; and foodservice hot beverage, foodservice portion control, and flour products, as well as dog and cat food, frozen handheld products, juices and beverages, and baking mixes and ingredients. It provides its products under the Meow Mix, Milk-Bone, Pup-Peroni, Canine Carry Outs, Folgers, Café Bustelo, Dunkin', Folgers, Café Bustelo, 1850, Jif, Smucker's, Smucker's Uncrustables, Robin Hood, and Five Roses. The company sells its products through direct sales and brokers to food retailers, club stores, discount and dollar stores, online retailers, pet specialty stores, natural foods stores and distributors, drug stores, military commissaries, and mass merchandisers. Smucker Company was founded in 1897 and is headquartered in Orrville, Ohio.